Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 20-F, Date: 2020-03-12, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CBPO/20200312/20-F_1/1/000.htm SEC Original: tmb-20191231x20fc97c9f.htm
(function() { var hostName = window.location.hostname; var browserAccepted = function() { var ua = window.navigator.userAgent; var trident = ua.indexOf(‘Trident/’); //IE 11; var msie = ua.indexOf(‘MSIE ‘); // IE 10 or older if (msie > 0) { return false; } return true; }(); var pathToLibs = ‘./js’; var pathToError = ‘/’; if (hostName === ‘www-test.sec.gov’ || hostName === ‘www.sec.gov’) { pathToLibs

---

---

Webplus: CBPO/20200312/20-F_1/2_EX-2.8/000.htm SEC Original: ex-2d8.htm
memorandum and articles of association and a Ordinary Shares General . All of our outstanding ordinary shares are fully paid and non-assessable. Our ordinary shares are issued in registered form, and are issued when entered in our register of members. Our shareholders who are non-residents of the Cayman Islands may freely hold and transfer their ordinary shares. Dividends Voting Rights

---

---

Webplus: CBPO/20200312/20-F_1/3_EX-4.40/000.htm SEC Original: ex-4d40.htm
Employment Agreement This Employment Agreement (this “ Agreement ”), dated as of August 16, 2019, is entered into between China Biologic Products Holdings, Inc., a company established in the Cayman Islands with its principal office located at 18th Floor, Jialong Int’l Tower, 19 Chaoyang Park Road, Beijing 100125, PRC (“ Company ”), and Joseph Chow (the “ Executive ”). WHEREAS,

---

---

Webplus: CBPO/20200312/20-F_1/4_EX-8.1/000.htm SEC Original: ex-8d1.htm
CHINA BIOLOGIC PRODUCTS HOLDINGS, INC Jurisdiction of Incorporation or Name Organization Taibang Biological Ltd. British Virgin Islands Taibang Holdings (Hong Kong) Limited Hong Kong Health Forward Holdings Limited Hong Kong TianXinFu (Beijing) Medical Appliance Co., Ltd. PRC Taibang Biotech (Shandong) Co., Ltd. PRC Taibang (Beijing) Pharmaceutical Research Institute Co., Ltd. PRC Shandong Taibang Biological Products Co., Ltd. PRC Qihe Antai

---

---

Webplus: CBPO/20200312/20-F_1/5_EX-12.1/000.htm SEC Original: ex-12d1.htm
Certification by the Chief Executive Officer I, Joseph Chow, certify that: 1. I have reviewed this annual report on Form 20-F of China Biologic Products Holdings, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in

---

---

Webplus: CBPO/20200312/20-F_1/6_EX-12.2/000.htm SEC Original: ex-12d2.htm
Certification by the Chief Financial Officer I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 20-F of China Biologic Products Holdings, Inc. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in

---

---

Webplus: CBPO/20200312/20-F_1/7_EX-13.1/000.htm SEC Original: ex-13d1.htm
Certification by the Chief Executive Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Joseph Chow Chief Executive Officer

---

---

Webplus: CBPO/20200312/20-F_1/8_EX-13.2/000.htm SEC Original: ex-13d2.htm
Certification by the Chief Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. By Ming Yang Chief Financial Officer

---

---

Webplus: CBPO/20200312/20-F_1/9_EX-15.1/000.htm SEC Original: ex-15d1.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors China Biologic Products Holdings, Inc. Our report on the consolidated financial statements refers to changes in the Company’s method of accounting for revenue recognition in 2018 due to the adoption of ASU No. 2014-09, Revenue from Contracts with Customers Leases Beijing, China March 12, 2020

---

Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: 20-F, Date: 2020-03-12, XBRL Interactive FinancialsCIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125